Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$3.38
+$0.11 (+3.36%)
Sep 22, 2026, 10:11 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.75 | -4.60 | -10.26 | -6 | -8.15 | -21.76 |
PEG Ratio | 0.07 | 0.71 | 0.98 | -0.28 | -1.28 | -0.45 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.41 | 2.57 | 5.11 | 2.72 | 3.04 | 6.03 |
P/FCF Ratio | -2.05 | -5.53 | -11.91 | -7.14 | -10.71 | -29.29 |
P/OCF Ratio | -2.05 | -5.68 | -12.92 | -7.49 | -11.39 | -40.69 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.09 | 0.06 | 0.05 | 0.05 | 0.05 | 0.12 |
Quick Ratio | 6.38 | 9.30 | 7.80 | 9.29 | 17.69 | 14.94 |
Current Ratio | 6.38 | 9.30 | 7.80 | 9.29 | 17.69 | 14.94 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -120.84 | -144.86 | -138.48 | -117.52 | -28.40 | -18.02 |
Return on Equity | -80.49% | -55.86% | -49.86% | -45.31% | -37.18% | -29.13% |
Return on Assets | -67.52% | -49.03% | -43.37% | -40.21% | -34.02% | -24.82% |
Return on Invested Capital | -75.38% | -55.77% | -49.88% | -43.55% | -35.03% | -24.06% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove RCKT